IPSS-R较IPSS更准确反映新诊断MDS患者疲劳严重程度
研究纳入927例新诊断MDS患者,基线完成FACIT-疲劳问卷,并与1075例一般人群比较。MDS患者疲劳评分平均低4.6分(95%CI -5.9至-3.2,p<0.001),具临床意义。IPSS-R能区分不同疲劳负担亚组,而IPSS不能。
要点
- 新诊断MDS患者疲劳显著差于一般人群,差异具临床意义。
- IPSS-R可分层疲劳严重程度,IPSS不能。
- 极低危IPSS-R疲劳差异无临床意义,极高危差异大。
核心结论
- 新诊断MDS患者疲劳较一般人群具临床意义地更差。
- IPSS-R较IPSS能更好分层患者疲劳严重程度。
研究设计与样本
- 国际观察性研究连续纳入927例新诊断MDS患者,基线完成FACIT-疲劳问卷。
- 疲劳评分与1075例一般人群比较,平均分差3分视为临床有意义。
主要发现
- MDS患者疲劳评分平均低于一般人群4.6分(95%CI -5.9至-3.2,p<0.001)。
- IPSS-R极低危组与一般人群差异无临床意义(Δ=-1.8,95%CI -4.0至0.5,p=0.119)。
- IPSS-R极高危组与一般人群差异大且具临床意义(Δ=-8.2,95%CI -10.3至-6.2,p<0.001)。
- IPSS未能识别疲劳负担明显不同的亚组。
关键数值与推荐
- FACIT-疲劳问卷平均分差3分视为临床有意义。
- IPSS-R极低危组Δ=-1.8(95%CI -4.0至0.5,p=0.119)。
- IPSS-R极高危组Δ=-8.2(95%CI -10.3至-6.2,p<0.001)。
临床怎么用
- 诊断评估时应关注MDS患者疲劳,尤其IPSS-R高危组。
- IPSS-R可用于识别疲劳负担更重的患者亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to compare fatigue of newly diagnosed patients with myelodysplastic syndromes (MDS) with that of the general population (GP). We also investigated the ability of the IPSS and IPSS-R to capture severity of patient-reported fatigue at diagnostic workup. A sample of 927 newly diagnosed patients with MDS was consecutively enrolled in a large international observational study and all patients completed the FACIT-Fatigue questionnaire at baseline. Fatigue was compared with that of the GP (N = 1075) and a 3-point difference in mean scores was considered as clinically meaningful. Fatigue of MDS patients was on average 4.6 points below the mean of the GP (95% CI, -5.9 to -3.2, p < 0.001), reflecting clinically meaningful worse fatigue. Unlike the IPSS, the IPSS-R identified clearly distinct subgroups with regard to burden of fatigue. Mean scores differences compared with GP ranged from nonclinically relevant for very low risk (Δ = -1.8, 95% CI, -4.0 to 0.5, p = 0.119) to large clinically meaningful differences for very high-risk IPSS-R patients (Δ = -8.2, 95% CI, -10.3 to -6.2, p < 0.001). At diagnostic workup, fatigue of MDS is clinically meaningful worse than that reported by the GP. Compared with the IPSS classification, the IPSS-R provides a better stratification of patients with regard to fatigue severity.
引用
- Efficace F, Cottone F, Oswald LB, et al. The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. Leukemia. 2020. PMID: 32086447. doi:10.1038/s41375-020-0746-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。